• Open Access

Clinical Translational Science 2020: Disruptive Innovation Redefines the Discovery-Application Enterprise


  • Scott A. Waldman,

    1. Department of Pharmacology and Experimental Therapeutics, Division of Clinical Pharmacology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA
    Search for more papers by this author
  • Andre Terzic

    1. Divisions of Cardiovascular Diseases and Clinical Pharmacology, Departments of Medicine, Molecular Pharmacology, and Experimental Therapeutics and Medical Genetics, Mayo Clinic, Rochester, MN, USA.
    Search for more papers by this author

SA Waldman (scott.waldman@jefferson.edu) or A Terzic (terzic.andre@mayo.edu)

No abstract is available for this article.